01 4LXO IRELAND
02 4NODEN PHARMA
03 6NOVARTIS
01 28168616
02 48613949
03 28617595
04 28617595*PED
05 48618172
01 14Blank
01 12Y
02 2Blank
01 22026-02-19
02 22026-07-03
03 22026-08-19
04 42028-07-13
05 42029-12-21
Patent Expiration Date : 2028-07-13
ALISKIREN HEMIFUMARATE; HYDROCHLOROTHIAZIDE
US Patent Number : 8618172
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 22107
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2028-07-13
Patent Expiration Date : 2028-07-13
ALISKIREN HEMIFUMARATE; HYDROCHLOROTHIAZIDE
US Patent Number : 8618172
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 22107
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2028-07-13
Patent Expiration Date : 2028-07-13
ALISKIREN HEMIFUMARATE; HYDROCHLOROTHIAZIDE
US Patent Number : 8618172
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 22107
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2028-07-13
Patent Expiration Date : 2028-07-13
ALISKIREN HEMIFUMARATE; HYDROCHLOROTHIAZIDE
US Patent Number : 8618172
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 22107
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2028-07-13
Patent Expiration Date : 2026-07-03
ALISKIREN HEMIFUMARATE; VALSARTAN
US Patent Number : 8168616
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 22217
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2026-07-03
Patent Expiration Date : 2029-12-21
ALISKIREN HEMIFUMARATE; AMLODIPINE BESYLATE
US Patent Number : 8613949
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 22545
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-12-21
Patent Expiration Date : 2029-12-21
ALISKIREN HEMIFUMARATE; AMLODIPINE BESYLATE
US Patent Number : 8613949
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 22545
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-12-21
Patent Expiration Date : 2029-12-21
ALISKIREN HEMIFUMARATE; AMLODIPINE BESYLATE
US Patent Number : 8613949
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 22545
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-12-21
Patent Expiration Date : 2029-12-21
ALISKIREN HEMIFUMARATE; AMLODIPINE BESYLATE
US Patent Number : 8613949
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 22545
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-12-21
Patent Expiration Date : 2026-07-03
ALISKIREN HEMIFUMARATE; VALSARTAN
US Patent Number : 8168616
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 22217
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2026-07-03
